A detailed history of Woodline Partners LP transactions in Kempharm, Inc stock. As of the latest transaction made, Woodline Partners LP holds 4,048,653 shares of KMPH stock, worth $20 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,048,653
Previous 1,147,583 252.8%
Holding current value
$20 Million
Previous $5.67 Million 252.8%
% of portfolio
0.18%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
2,901,070 Added 252.8%
4,048,653 $20 Million
Q2 2024

Aug 14, 2024

BUY
N/A
137,966 Added 13.67%
1,147,583 $5.67 Million
Q1 2024

May 15, 2024

BUY
N/A
1,009,617 New
1,009,617 $4.99 Million

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.